Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor NGS Genetic Testing Market Size Growth Rate by Type: 2024 VS 2022 VS 2034
1.2.2 Liquid Biopsy (Blood Sample)
1.2.3 Tissue Biopsy
1.3 Market by Application
1.3.1 Global Tumor NGS Genetic Testing Market Growth by Application: 2024 VS 2022 VS 2034
1.3.2 Companion Diagnostics
1.3.3 Early Cancer Screening
1.3.4 Drug Discovery
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor NGS Genetic Testing Market Perspective (2024-2034)
2.2 Tumor NGS Genetic Testing Growth Trends by Region
2.2.1 Global Tumor NGS Genetic Testing Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 Tumor NGS Genetic Testing Historic Market Size by Region (2024-2024)
2.2.3 Tumor NGS Genetic Testing Forecasted Market Size by Region (2024-2034)
2.3 Tumor NGS Genetic Testing Market Dynamics
2.3.1 Tumor NGS Genetic Testing Industry Trends
2.3.2 Tumor NGS Genetic Testing Market Drivers
2.3.3 Tumor NGS Genetic Testing Market Challenges
2.3.4 Tumor NGS Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor NGS Genetic Testing Players by Revenue
3.1.1 Global Top Tumor NGS Genetic Testing Players by Revenue (2024-2024)
3.1.2 Global Tumor NGS Genetic Testing Revenue Market Share by Players (2024-2024)
3.2 Global Tumor NGS Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tumor NGS Genetic Testing Revenue
3.4 Global Tumor NGS Genetic Testing Market Concentration Ratio
3.4.1 Global Tumor NGS Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor NGS Genetic Testing Revenue in 2022
3.5 Tumor NGS Genetic Testing Key Players Head office and Area Served
3.6 Key Players Tumor NGS Genetic Testing Product Solution and Service
3.7 Date of Enter into Tumor NGS Genetic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor NGS Genetic Testing Breakdown Data by Type
4.1 Global Tumor NGS Genetic Testing Historic Market Size by Type (2024-2024)
4.2 Global Tumor NGS Genetic Testing Forecasted Market Size by Type (2024-2034)
5 Tumor NGS Genetic Testing Breakdown Data by Application
5.1 Global Tumor NGS Genetic Testing Historic Market Size by Application (2024-2024)
5.2 Global Tumor NGS Genetic Testing Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Tumor NGS Genetic Testing Market Size (2024-2034)
6.2 North America Tumor NGS Genetic Testing Market Growth Rate by Country: 2024 VS 2022 VS 2034
6.3 North America Tumor NGS Genetic Testing Market Size by Country (2024-2024)
6.4 North America Tumor NGS Genetic Testing Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor NGS Genetic Testing Market Size (2024-2034)
7.2 Europe Tumor NGS Genetic Testing Market Growth Rate by Country: 2024 VS 2022 VS 2034
7.3 Europe Tumor NGS Genetic Testing Market Size by Country (2024-2024)
7.4 Europe Tumor NGS Genetic Testing Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor NGS Genetic Testing Market Size (2024-2034)
8.2 Asia-Pacific Tumor NGS Genetic Testing Market Growth Rate by Region: 2024 VS 2022 VS 2034
8.3 Asia-Pacific Tumor NGS Genetic Testing Market Size by Region (2024-2024)
8.4 Asia-Pacific Tumor NGS Genetic Testing Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor NGS Genetic Testing Market Size (2024-2034)
9.2 Latin America Tumor NGS Genetic Testing Market Growth Rate by Country: 2024 VS 2022 VS 2034
9.3 Latin America Tumor NGS Genetic Testing Market Size by Country (2024-2024)
9.4 Latin America Tumor NGS Genetic Testing Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor NGS Genetic Testing Market Size (2024-2034)
10.2 Middle East & Africa Tumor NGS Genetic Testing Market Growth Rate by Country: 2024 VS 2022 VS 2034
10.3 Middle East & Africa Tumor NGS Genetic Testing Market Size by Country (2024-2024)
10.4 Middle East & Africa Tumor NGS Genetic Testing Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Foundation Medicine
11.1.1 Foundation Medicine Company Detail
11.1.2 Foundation Medicine Business Overview
11.1.3 Foundation Medicine Tumor NGS Genetic Testing Introduction
11.1.4 Foundation Medicine Revenue in Tumor NGS Genetic Testing Business (2024-2024)
11.1.5 Foundation Medicine Recent Development
11.2 Guardant Health
11.2.1 Guardant Health Company Detail
11.2.2 Guardant Health Business Overview
11.2.3 Guardant Health Tumor NGS Genetic Testing Introduction
11.2.4 Guardant Health Revenue in Tumor NGS Genetic Testing Business (2024-2024)
11.2.5 Guardant Health Recent Development
11.3 Illumina
11.3.1 Illumina Company Detail
11.3.2 Illumina Business Overview
11.3.3 Illumina Tumor NGS Genetic Testing Introduction
11.3.4 Illumina Revenue in Tumor NGS Genetic Testing Business (2024-2024)
11.3.5 Illumina Recent Development
11.4 Thermo Fisher Scientific Inc.
11.4.1 Thermo Fisher Scientific Inc. Company Detail
11.4.2 Thermo Fisher Scientific Inc. Business Overview
11.4.3 Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Introduction
11.4.4 Thermo Fisher Scientific Inc. Revenue in Tumor NGS Genetic Testing Business (2024-2024)
11.4.5 Thermo Fisher Scientific Inc. Recent Development
11.5 DIAN DIAGNOSTICS Group Co., Ltd.
11.5.1 DIAN DIAGNOSTICS Group Co., Ltd. Company Detail
11.5.2 DIAN DIAGNOSTICS Group Co., Ltd. Business Overview
11.5.3 DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Introduction
11.5.4 DIAN DIAGNOSTICS Group Co., Ltd. Revenue in Tumor NGS Genetic Testing Business (2024-2024)
11.5.5 DIAN DIAGNOSTICS Group Co., Ltd. Recent Development
11.6 Burning Rock Biotech.
11.6.1 Burning Rock Biotech. Company Detail
11.6.2 Burning Rock Biotech. Business Overview
11.6.3 Burning Rock Biotech. Tumor NGS Genetic Testing Introduction
11.6.4 Burning Rock Biotech. Revenue in Tumor NGS Genetic Testing Business (2024-2024)
11.6.5 Burning Rock Biotech. Recent Development
11.7 NovogeneCo.,Ltd.
11.7.1 NovogeneCo.,Ltd. Company Detail
11.7.2 NovogeneCo.,Ltd. Business Overview
11.7.3 NovogeneCo.,Ltd. Tumor NGS Genetic Testing Introduction
11.7.4 NovogeneCo.,Ltd. Revenue in Tumor NGS Genetic Testing Business (2024-2024)
11.7.5 NovogeneCo.,Ltd. Recent Development
11.8 Nanjing Shihejiyin Technology, Inc.
11.8.1 Nanjing Shihejiyin Technology, Inc. Company Detail
11.8.2 Nanjing Shihejiyin Technology, Inc. Business Overview
11.8.3 Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Introduction
11.8.4 Nanjing Shihejiyin Technology, Inc. Revenue in Tumor NGS Genetic Testing Business (2024-2024)
11.8.5 Nanjing Shihejiyin Technology, Inc. Recent Development
11.9 Amoy Diagnostics Co.,Ltd.
11.9.1 Amoy Diagnostics Co.,Ltd. Company Detail
11.9.2 Amoy Diagnostics Co.,Ltd. Business Overview
11.9.3 Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Introduction
11.9.4 Amoy Diagnostics Co.,Ltd. Revenue in Tumor NGS Genetic Testing Business (2024-2024)
11.9.5 Amoy Diagnostics Co.,Ltd. Recent Development
11.10 China National Pharmaceutical Group Corporation
11.10.1 China National Pharmaceutical Group Corporation Company Detail
11.10.2 China National Pharmaceutical Group Corporation Business Overview
11.10.3 China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Introduction
11.10.4 China National Pharmaceutical Group Corporation Revenue in Tumor NGS Genetic Testing Business (2024-2024)
11.10.5 China National Pharmaceutical Group Corporation Recent Development
11.11 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
11.11.1 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Company Detail
11.11.2 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Business Overview
11.11.3 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Introduction
11.11.4 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Revenue in Tumor NGS Genetic Testing Business (2024-2024)
11.11.5 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Recent Development
11.12 Guangzhou Kingmed Diagnostics Group Co.,Ltd.
11.12.1 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Company Detail
11.12.2 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Business Overview
11.12.3 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Introduction
11.12.4 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Revenue in Tumor NGS Genetic Testing Business (2024-2024)
11.12.5 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Recent Development
11.13 ADICON Clinical Laboratories, Inc.
11.13.1 ADICON Clinical Laboratories, Inc. Company Detail
11.13.2 ADICON Clinical Laboratories, Inc. Business Overview
11.13.3 ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Introduction
11.13.4 ADICON Clinical Laboratories, Inc. Revenue in Tumor NGS Genetic Testing Business (2024-2024)
11.13.5 ADICON Clinical Laboratories, Inc. Recent Development
11.14 Genetron
11.14.1 Genetron Company Detail
11.14.2 Genetron Business Overview
11.14.3 Genetron Tumor NGS Genetic Testing Introduction
11.14.4 Genetron Revenue in Tumor NGS Genetic Testing Business (2024-2024)
11.14.5 Genetron Recent Development
11.15 Genecast Group Inc.
11.15.1 Genecast Group Inc. Company Detail
11.15.2 Genecast Group Inc. Business Overview
11.15.3 Genecast Group Inc. Tumor NGS Genetic Testing Introduction
11.15.4 Genecast Group Inc. Revenue in Tumor NGS Genetic Testing Business (2024-2024)
11.15.5 Genecast Group Inc. Recent Development
11.16 BGI Genomics Co.,Ltd.
11.16.1 BGI Genomics Co.,Ltd. Company Detail
11.16.2 BGI Genomics Co.,Ltd. Business Overview
11.16.3 BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Introduction
11.16.4 BGI Genomics Co.,Ltd. Revenue in Tumor NGS Genetic Testing Business (2024-2024)
11.16.5 BGI Genomics Co.,Ltd. Recent Development
11.17 Beijing-Geneplus Technology Limited.
11.17.1 Beijing-Geneplus Technology Limited. Company Detail
11.17.2 Beijing-Geneplus Technology Limited. Business Overview
11.17.3 Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Introduction
11.17.4 Beijing-Geneplus Technology Limited. Revenue in Tumor NGS Genetic Testing Business (2024-2024)
11.17.5 Beijing-Geneplus Technology Limited. Recent Development
11.18 Xiamen SpacegenCo., Ltd.
11.18.1 Xiamen SpacegenCo., Ltd. Company Detail
11.18.2 Xiamen SpacegenCo., Ltd. Business Overview
11.18.3 Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Introduction
11.18.4 Xiamen SpacegenCo., Ltd. Revenue in Tumor NGS Genetic Testing Business (2024-2024)
11.18.5 Xiamen SpacegenCo., Ltd. Recent Development
11.19 Geneis（Beijing）Co.Ltd.
11.19.1 Geneis（Beijing）Co.Ltd. Company Detail
11.19.2 Geneis（Beijing）Co.Ltd. Business Overview
11.19.3 Geneis（Beijing）Co.Ltd. Tumor NGS Genetic Testing Introduction
11.19.4 Geneis（Beijing）Co.Ltd. Revenue in Tumor NGS Genetic Testing Business (2024-2024)
11.19.5 Geneis（Beijing）Co.Ltd. Recent Development
11.20 HaploX
11.20.1 HaploX Company Detail
11.20.2 HaploX Business Overview
11.20.3 HaploX Tumor NGS Genetic Testing Introduction
11.20.4 HaploX Revenue in Tumor NGS Genetic Testing Business (2024-2024)
11.20.5 HaploX Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Tumor NGS Genetic Testing Market Size Growth Rate by Type (US$ Million): 2024 VS 2022 VS 2034
Table 2. Key Players of Liquid Biopsy (Blood Sample)
Table 3. Key Players of Tissue Biopsy
Table 4. Global Tumor NGS Genetic Testing Market Size Growth by Application (US$ Million): 2024 VS 2022 VS 2034
Table 5. Global Tumor NGS Genetic Testing Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 6. Global Tumor NGS Genetic Testing Market Size by Region (2024-2024) & (US$ Million)
Table 7. Global Tumor NGS Genetic Testing Market Share by Region (2024-2024)
Table 8. Global Tumor NGS Genetic Testing Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Tumor NGS Genetic Testing Market Share by Region (2024-2034)
Table 10. Tumor NGS Genetic Testing Market Trends
Table 11. Tumor NGS Genetic Testing Market Drivers
Table 12. Tumor NGS Genetic Testing Market Challenges
Table 13. Tumor NGS Genetic Testing Market Restraints
Table 14. Global Tumor NGS Genetic Testing Revenue by Players (2024-2024) & (US$ Million)
Table 15. Global Tumor NGS Genetic Testing Market Share by Players (2024-2024)
Table 16. Global Top Tumor NGS Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor NGS Genetic Testing as of 2022)
Table 17. Ranking of Global Top Tumor NGS Genetic Testing Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Tumor NGS Genetic Testing Revenue (CR5 and HHI) & (2024-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Tumor NGS Genetic Testing Product Solution and Service
Table 21. Date of Enter into Tumor NGS Genetic Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Tumor NGS Genetic Testing Market Size by Type (2024-2024) & (US$ Million)
Table 24. Global Tumor NGS Genetic Testing Revenue Market Share by Type (2024-2024)
Table 25. Global Tumor NGS Genetic Testing Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Tumor NGS Genetic Testing Revenue Market Share by Type (2024-2034)
Table 27. Global Tumor NGS Genetic Testing Market Size by Application (2024-2024) & (US$ Million)
Table 28. Global Tumor NGS Genetic Testing Revenue Market Share by Application (2024-2024)
Table 29. Global Tumor NGS Genetic Testing Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Tumor NGS Genetic Testing Revenue Market Share by Application (2024-2034)
Table 31. North America Tumor NGS Genetic Testing Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 32. North America Tumor NGS Genetic Testing Market Size by Country (2024-2024) & (US$ Million)
Table 33. North America Tumor NGS Genetic Testing Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Tumor NGS Genetic Testing Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 35. Europe Tumor NGS Genetic Testing Market Size by Country (2024-2024) & (US$ Million)
Table 36. Europe Tumor NGS Genetic Testing Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Tumor NGS Genetic Testing Market Size Growth Rate by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Asia-Pacific Tumor NGS Genetic Testing Market Size by Region (2024-2024) & (US$ Million)
Table 39. Asia-Pacific Tumor NGS Genetic Testing Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Tumor NGS Genetic Testing Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 41. Latin America Tumor NGS Genetic Testing Market Size by Country (2024-2024) & (US$ Million)
Table 42. Latin America Tumor NGS Genetic Testing Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Tumor NGS Genetic Testing Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 44. Middle East & Africa Tumor NGS Genetic Testing Market Size by Country (2024-2024) & (US$ Million)
Table 45. Middle East & Africa Tumor NGS Genetic Testing Market Size by Country (2024-2034) & (US$ Million)
Table 46. Foundation Medicine Company Detail
Table 47. Foundation Medicine Business Overview
Table 48. Foundation Medicine Tumor NGS Genetic Testing Product
Table 49. Foundation Medicine Revenue in Tumor NGS Genetic Testing Business (2024-2024) & (US$ Million)
Table 50. Foundation Medicine Recent Development
Table 51. Guardant Health Company Detail
Table 52. Guardant Health Business Overview
Table 53. Guardant Health Tumor NGS Genetic Testing Product
Table 54. Guardant Health Revenue in Tumor NGS Genetic Testing Business (2024-2024) & (US$ Million)
Table 55. Guardant Health Recent Development
Table 56. Illumina Company Detail
Table 57. Illumina Business Overview
Table 58. Illumina Tumor NGS Genetic Testing Product
Table 59. Illumina Revenue in Tumor NGS Genetic Testing Business (2024-2024) & (US$ Million)
Table 60. Illumina Recent Development
Table 61. Thermo Fisher Scientific Inc. Company Detail
Table 62. Thermo Fisher Scientific Inc. Business Overview
Table 63. Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Product
Table 64. Thermo Fisher Scientific Inc. Revenue in Tumor NGS Genetic Testing Business (2024-2024) & (US$ Million)
Table 65. Thermo Fisher Scientific Inc. Recent Development
Table 66. DIAN DIAGNOSTICS Group Co., Ltd. Company Detail
Table 67. DIAN DIAGNOSTICS Group Co., Ltd. Business Overview
Table 68. DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Product
Table 69. DIAN DIAGNOSTICS Group Co., Ltd. Revenue in Tumor NGS Genetic Testing Business (2024-2024) & (US$ Million)
Table 70. DIAN DIAGNOSTICS Group Co., Ltd. Recent Development
Table 71. Burning Rock Biotech. Company Detail
Table 72. Burning Rock Biotech. Business Overview
Table 73. Burning Rock Biotech. Tumor NGS Genetic Testing Product
Table 74. Burning Rock Biotech. Revenue in Tumor NGS Genetic Testing Business (2024-2024) & (US$ Million)
Table 75. Burning Rock Biotech. Recent Development
Table 76. NovogeneCo.,Ltd. Company Detail
Table 77. NovogeneCo.,Ltd. Business Overview
Table 78. NovogeneCo.,Ltd. Tumor NGS Genetic Testing Product
Table 79. NovogeneCo.,Ltd. Revenue in Tumor NGS Genetic Testing Business (2024-2024) & (US$ Million)
Table 80. NovogeneCo.,Ltd. Recent Development
Table 81. Nanjing Shihejiyin Technology, Inc. Company Detail
Table 82. Nanjing Shihejiyin Technology, Inc. Business Overview
Table 83. Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Product
Table 84. Nanjing Shihejiyin Technology, Inc. Revenue in Tumor NGS Genetic Testing Business (2024-2024) & (US$ Million)
Table 85. Nanjing Shihejiyin Technology, Inc. Recent Development
Table 86. Amoy Diagnostics Co.,Ltd. Company Detail
Table 87. Amoy Diagnostics Co.,Ltd. Business Overview
Table 88. Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Product
Table 89. Amoy Diagnostics Co.,Ltd. Revenue in Tumor NGS Genetic Testing Business (2024-2024) & (US$ Million)
Table 90. Amoy Diagnostics Co.,Ltd. Recent Development
Table 91. China National Pharmaceutical Group Corporation Company Detail
Table 92. China National Pharmaceutical Group Corporation Business Overview
Table 93. China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Product
Table 94. China National Pharmaceutical Group Corporation Revenue in Tumor NGS Genetic Testing Business (2024-2024) & (US$ Million)
Table 95. China National Pharmaceutical Group Corporation Recent Development
Table 96. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Company Detail
Table 97. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Business Overview
Table 98. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Product
Table 99. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Revenue in Tumor NGS Genetic Testing Business (2024-2024) & (US$ Million)
Table 100. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Recent Development
Table 101. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Company Detail
Table 102. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Business Overview
Table 103. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Product
Table 104. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Revenue in Tumor NGS Genetic Testing Business (2024-2024) & (US$ Million)
Table 105. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Recent Development
Table 106. ADICON Clinical Laboratories, Inc. Company Detail
Table 107. ADICON Clinical Laboratories, Inc. Business Overview
Table 108. ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Product
Table 109. ADICON Clinical Laboratories, Inc. Revenue in Tumor NGS Genetic Testing Business (2024-2024) & (US$ Million)
Table 110. ADICON Clinical Laboratories, Inc. Recent Development
Table 111. Genetron Company Detail
Table 112. Genetron Business Overview
Table 113. Genetron Tumor NGS Genetic Testing Product
Table 114. Genetron Revenue in Tumor NGS Genetic Testing Business (2024-2024) & (US$ Million)
Table 115. Genetron Recent Development
Table 116. Genecast Group Inc. Company Detail
Table 117. Genecast Group Inc. Business Overview
Table 118. Genecast Group Inc. Tumor NGS Genetic Testing Product
Table 119. Genecast Group Inc. Revenue in Tumor NGS Genetic Testing Business (2024-2024) & (US$ Million)
Table 120. Genecast Group Inc. Recent Development
Table 121. BGI Genomics Co.,Ltd. Company Detail
Table 122. BGI Genomics Co.,Ltd. Business Overview
Table 123. BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Product
Table 124. BGI Genomics Co.,Ltd. Revenue in Tumor NGS Genetic Testing Business (2024-2024) & (US$ Million)
Table 125. BGI Genomics Co.,Ltd. Recent Development
Table 126. Beijing-Geneplus Technology Limited. Company Detail
Table 127. Beijing-Geneplus Technology Limited. Business Overview
Table 128. Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Product
Table 129. Beijing-Geneplus Technology Limited. Revenue in Tumor NGS Genetic Testing Business (2024-2024) & (US$ Million)
Table 130. Beijing-Geneplus Technology Limited. Recent Development
Table 131. Xiamen SpacegenCo., Ltd. Company Detail
Table 132. Xiamen SpacegenCo., Ltd. Business Overview
Table 133. Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Product
Table 134. Xiamen SpacegenCo., Ltd. Revenue in Tumor NGS Genetic Testing Business (2024-2024) & (US$ Million)
Table 135. Xiamen SpacegenCo., Ltd. Recent Development
Table 136. Geneis（Beijing）Co.Ltd. Company Detail
Table 137. Geneis（Beijing）Co.Ltd. Business Overview
Table 138. Geneis（Beijing）Co.Ltd. Tumor NGS Genetic Testing Product
Table 139. Geneis（Beijing）Co.Ltd. Revenue in Tumor NGS Genetic Testing Business (2024-2024) & (US$ Million)
Table 140. Geneis（Beijing）Co.Ltd. Recent Development
Table 141. HaploX Company Detail
Table 142. HaploX Business Overview
Table 143. HaploX Tumor NGS Genetic Testing Product
Table 144. HaploX Revenue in Tumor NGS Genetic Testing Business (2024-2024) & (US$ Million)
Table 145. HaploX Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tumor NGS Genetic Testing Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Tumor NGS Genetic Testing Market Share by Type: 2022 VS 2034
Figure 3. Liquid Biopsy (Blood Sample) Features
Figure 4. Tissue Biopsy Features
Figure 5. Global Tumor NGS Genetic Testing Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Tumor NGS Genetic Testing Market Share by Application: 2022 VS 2034
Figure 7. Companion Diagnostics Case Studies
Figure 8. Early Cancer Screening Case Studies
Figure 9. Drug Discovery Case Studies
Figure 10. Tumor NGS Genetic Testing Report Years Considered
Figure 11. Global Tumor NGS Genetic Testing Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 12. Global Tumor NGS Genetic Testing Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 13. Global Tumor NGS Genetic Testing Market Share by Region: 2022 VS 2034
Figure 14. Global Tumor NGS Genetic Testing Market Share by Players in 2022
Figure 15. Global Top Tumor NGS Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor NGS Genetic Testing as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Tumor NGS Genetic Testing Revenue in 2022
Figure 17. North America Tumor NGS Genetic Testing Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 18. North America Tumor NGS Genetic Testing Market Share by Country (2024-2034)
Figure 19. United States Tumor NGS Genetic Testing Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 20. Canada Tumor NGS Genetic Testing Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 21. Europe Tumor NGS Genetic Testing Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 22. Europe Tumor NGS Genetic Testing Market Share by Country (2024-2034)
Figure 23. Germany Tumor NGS Genetic Testing Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 24. France Tumor NGS Genetic Testing Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 25. U.K. Tumor NGS Genetic Testing Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 26. Italy Tumor NGS Genetic Testing Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 27. Russia Tumor NGS Genetic Testing Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 28. Nordic Countries Tumor NGS Genetic Testing Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. Asia-Pacific Tumor NGS Genetic Testing Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 30. Asia-Pacific Tumor NGS Genetic Testing Market Share by Region (2024-2034)
Figure 31. China Tumor NGS Genetic Testing Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 32. Japan Tumor NGS Genetic Testing Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 33. South Korea Tumor NGS Genetic Testing Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 34. Southeast Asia Tumor NGS Genetic Testing Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 35. India Tumor NGS Genetic Testing Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 36. Australia Tumor NGS Genetic Testing Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 37. Latin America Tumor NGS Genetic Testing Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 38. Latin America Tumor NGS Genetic Testing Market Share by Country (2024-2034)
Figure 39. Mexico Tumor NGS Genetic Testing Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 40. Brazil Tumor NGS Genetic Testing Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 41. Middle East & Africa Tumor NGS Genetic Testing Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 42. Middle East & Africa Tumor NGS Genetic Testing Market Share by Country (2024-2034)
Figure 43. Turkey Tumor NGS Genetic Testing Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 44. Saudi Arabia Tumor NGS Genetic Testing Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 45. Foundation Medicine Revenue Growth Rate in Tumor NGS Genetic Testing Business (2024-2024)
Figure 46. Guardant Health Revenue Growth Rate in Tumor NGS Genetic Testing Business (2024-2024)
Figure 47. Illumina Revenue Growth Rate in Tumor NGS Genetic Testing Business (2024-2024)
Figure 48. Thermo Fisher Scientific Inc. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2024-2024)
Figure 49. DIAN DIAGNOSTICS Group Co., Ltd. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2024-2024)
Figure 50. Burning Rock Biotech. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2024-2024)
Figure 51. NovogeneCo.,Ltd. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2024-2024)
Figure 52. Nanjing Shihejiyin Technology, Inc. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2024-2024)
Figure 53. Amoy Diagnostics Co.,Ltd. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2024-2024)
Figure 54. China National Pharmaceutical Group Corporation Revenue Growth Rate in Tumor NGS Genetic Testing Business (2024-2024)
Figure 55. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2024-2024)
Figure 56. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2024-2024)
Figure 57. ADICON Clinical Laboratories, Inc. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2024-2024)
Figure 58. Genetron Revenue Growth Rate in Tumor NGS Genetic Testing Business (2024-2024)
Figure 59. Genecast Group Inc. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2024-2024)
Figure 60. BGI Genomics Co.,Ltd. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2024-2024)
Figure 61. Beijing-Geneplus Technology Limited. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2024-2024)
Figure 62. Xiamen SpacegenCo., Ltd. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2024-2024)
Figure 63. Geneis（Beijing）Co.Ltd. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2024-2024)
Figure 64. HaploX Revenue Growth Rate in Tumor NGS Genetic Testing Business (2024-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed